TrialAIDS research and human retroviruses2013

Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study.

Kathleen E Squires et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.